Heartburn, Dyspepsia&Intestinal Gas Flashcards
Heartburn
Burning sensation in the stomach or lower chest that rises up toward the neck
Dyspepsia
Symptoms originating from the gastroscope always region ( e.g. postpradial fullness, early satiation, epigastric pain, and epigastric burning):
- organic-identifiable cause
- functional- no identifiable ( organic, systemic or metabolic) causes
Diet as risk factors
Alcohol Caffeine Fatty food Salt Spicy food
Life style as risk factors
Exercise Obesity Smoking Stress Tight-fitting clothing
Disease as risk factors
Motility disorder
PUD
Scleroderma
Medications as risk factors
Alpha-adrenergic antagonist Anticholinergic Barbiturates Benzodiazepines Beta2-adrenergic agonist Bisphosphonates TCAs Tetracycline
Heartburn (pyrosis) clinical presentation
Usually 1 hour after eating a large meal
-bending over/lying down can aggravate symptoms
Occurring >_2 time a week => GERD
Nocturnal symptoms
-associated with interrupted sleep, decreased productivity
Alarm symptoms
-dysphasia, odynophagia, upper GI bleeding, unexplained weight loss
Dyspepsia
“B” symptoms- burping, benching, bloating
Feeling full early ( satiety)
Treatment goals
Provide complete relief of symptoms
Reduce recurrence of symptoms
Prevention and management unwanted effects of medications
Exclusions for self treatment
Frequent heartburn for >3 months
Heartburn while taking nonprescription H2RA or PPI
Heartburn and dyspepsia that occurs when taking a prescription H2RA or PPI
Heartburn continues after 2 weeks of treatment with otc H2RA or PPI
Severe heartburn and dyspepsia
Nocturnal heartburn
Difficulty or pain on swallowing solid foods
Vomiting up blood or black material or passing black tarry stools
Chronic hoarseness wheezing coughing, or choking
Unexplained weight loss
Continuous nausea, vomiting or diarrhea
Chest pain accompanied by sweating, pain, radiating to shoulder arm, neck or jaw, and shortness of breath
Children <2 years ( for antacid) , 12 year ( for H2RA), and 18 yo ( for PPI)
Adults >45 yo with new onset dyspepsia
Nonpharmacologic Treatment
Avoid food/beverages that precipitate heartburn
Adopt lifestyle modification that reduce esophageal acid exposure
Weight loss
Elevating head of bed by by place 6 to 8 inches blocks underneath legs at the head of the bed
Eat smaller meals to reduce dietary fat intake
Do not eat within 3 hours of going to bed / lying down
Antacids
Magnesium
Aluminum
Calcium
Sodium bicarbonate
Pharmacologic Treatment
Antacid
Histamine type 2 receptors antagonist
PPI
Bismuth sub salicylate
Antacid onset and duration in relief heartburn
Onset <5 min
Duration of relief 20-30 min
H2RA onset and duration in relief heartburn
Onset 30-45 min
Duration of relief 4-10 hr
H2RA +antacid onset and duration in relief heartburn
Onset <5 min
Duration of relief 8-10 hr
PPI onset and duration in relief heartburn
Onset 2-3 hr
Duration of relief 12-24
Antacid indications
Treatment of mild , infrequent heartburn
Antacid MOA
Neutralizes gastric acid ( buffering agents), increases intragastric pH > 5 to prevent conversions of pepsin to pepsinogen and increase LES pressure
Antacid ANC ( acid neutralizing capacity)
Amount of acid buffered per dose over a period of time
Antacid gen info
Compared with tablets, liquid antacid usually have a faster onset
Most Antacid are absorbed minimally into systemic circulation:
10% of calcium salt
15-30% of magnesium salts excreted renally, careful with renal impairment
17-30% of aluminum salts excreted renally, careful with renal impairment
Antacid dose at onset symptoms
May repeat in 1-2 hours, if needed
Antacid ADE magnesium
Magnesium: dose related diarrhea, not used in renal impairment patients ( CrCl< 30 ml/ minutes)
Antacid ADE aluminum
Aluminum: dose related constipation, hypophosphatemia ( with prolonged use, aluminum binds dietary phosphate)
Aluminum Toxicity in renal failure
Antacid ADE calcium
Belching, flatulence, constipation
Hypcalcemia( renally impaired)
Antacid ADE sodium bicarbonate
Belching , flatulence
Not used in aCHF, renal failure, cirrhosis or pregnancy => fluid overload
Milk-alkali Syndrome ( high intake of calcium with alkalizing agent)
- hypercalcemia, alkalosis, irritability, headache, nausea, vomiting, weakness, and malaise
Antacid DDI
Affects absorption of other medications ( increase/decreases)
Antibiotic ( decreased absorption)
- flouroquinolones, azithromycon, tetracycline
Anti fungal ( decreases absorption)
- intracinazole, ketoconazole
Recommended: separate medications with potential DDI by at least 2 hours before meal or 4 hours after meal
H2RA indications
Treatment of mild to moderate, infrequent or episodic heartburn and prevention of heartburn
H2RA MOA
Decrease gastric acid secretions and gastric volume by inhibiting histamine on the histamine type 2 receptor Of parietal cell
H2RA shortest acting
Cemitidine
H2RA dose reduction
Renally impaired and geriatrics
H2RA tolerance
To gastric antisecretory effect may develop when H2RA are taking daily so better to take it on as needed basis